M
Matthew W. Watkins
Researcher at University of Vermont
Publications - 48
Citations - 3214
Matthew W. Watkins is an academic researcher from University of Vermont. The author has contributed to research in topics: Placebo & Percutaneous coronary intervention. The author has an hindex of 20, co-authored 47 publications receiving 3099 citations. Previous affiliations of Matthew W. Watkins include Beaumont Hospital & University of Vermont Medical Center.
Papers
More filters
Journal ArticleDOI
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee).
Christopher P. Cannon,Alexander Battler,Ralph G. Brindis,Jafna L. Cox,Stephen G. Ellis,Nathan R. Every,John T. Flaherty,Robert A. Harrington,Harlan M. Krumholz,Maarten L. Simoons,Frans Van de Werf,William S. Weintraub,Kristi Mitchell,Susan L Morrisson,H. Vernon Anderson,David S. Cannom,W. Randolph Chitwood,Joaquin E. Cigarroa,Ruth L. Collins-Nakai,Raymond J. Gibbons,Frederick L. Grover,Paul A. Heidenreich,Bijoy K. Khandheria,Suzanne B. Knoebel,Harlan L Krumholz,David J. Malenka,Daniel B. Mark,Charles R. McKay,Eugene R. Passamani,Martha J. Radford,Ronald N Riner,Janice B. Schwartz,Richard E. Shaw,Richard J. Shemin,Douglas B. Van Fossen,Edward D. Verrier,Matthew W. Watkins,Dawn R. Phoubandith,Tori Furnelli +38 more
Journal ArticleDOI
Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
Cindy L. Grines,Matthew W. Watkins,Greg Helmer,William F. Penny,Jeffrey Brinker,Jonathan D. Marmur,Andrew West,Jeffery J. Rade,Pran Marrott,H. Kirk Hammond,Robert L. Engler +10 more
TL;DR: Angiogenic gene transfer with Ad5-FGF4 shows promise as a new therapeutic approach to the treatment of angina pectoris and it appears to be safe.
Journal ArticleDOI
A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina
Cindy L. Grines,Matthew W. Watkins,John J. Mahmarian,Ami E. Iskandrian,Jeffrey J. Rade,Pran Marrott,Craig M. Pratt,Neal S. Kleiman +7 more
TL;DR: Intracoronary injection of Ad5FGF-4 showed an encouraging trend for improved myocardial perfusion; however, further studies of therapeutic angiogenesis with Ad 5F GF-4 will be necessary.
Journal ArticleDOI
Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study
Nathaniel W. Niles,Paul D McGrath,David J. Malenka,Hebe B. Quinton,David E. Wennberg,Samuel J. Shubrooks,Joan F. Tryzelaar,Robert A. Clough,Michael J. Hearne,Felix Hernandez,Matthew W. Watkins,Gerald T. O'Connor +11 more
TL;DR: Five-year mortality was significantly increased after initial percutaneous coronary intervention and this supports the BARI conclusion on initial revascularization of patients with diabetes and MVD.
Journal ArticleDOI
Predicting vascular complications in percutaneous coronary interventions.
Winthrop D Piper,David J. Malenka,Thomas J. Ryan,Samuel J. Shubrooks,Gerald T. O'Connor,Gerald T. O'Connor,John F. Robb,Karen L Farrell,Mary S Corliss,Michael J. Hearne,Mirle A. Kellett,Matthew W. Watkins,William A. Bradley,Bruce D. Hettleman,Theodore M Silver,Paul D McGrath,John R O’Mears,David E. Wennberg +17 more
TL;DR: Predicting the risk of post-PCI vascular complications is feasible and may be useful for clinical decision-making and institutional efforts at quality improvement.